Media Coverage

The rate of workforce drug positivity hit a fourteen-year high in 2018, according to a new analysis released today by Quest Diagnostics. Positivity rates in the combined U.S. workforce increased nearly 5% in urine drug tests (4.2% in 2017 versus 4.4% in 2018), climbing to the highest level since 2004 (4.5%) and are now more than 2% higher than the thirty-year low of 3.5% recorded between 2010 and 2012. The new findings of the Quest Diagnostics Drug Testing Index™ were unveiled on April 11 at the Drug and Alcohol Testing Industry Association (DATIA) annual conference in Chicago.

Last year saw the highest percentage of positive workplace drug tests since 2004, with 4.4% of American workers showing traces of drugs such as marijuana, amphetamines, opiates, cocaine, and heroin in their systems, according to the results of a new study published Wednesday. Key findings from a Quest Diagnostics analysis.

The rate of American workers testing positive in workplace drug tests hit a 14-year high in 2018, driven by an uptick in marijuana use, a new analysis found. Last year, 4.4% of workers and job applicants tested positive for drugs, a 5% increase over 2017 and the highest mark since 2004, according to an analysis of more than 10 million workplace drug tests released Thursday by Quest Diagnostics, one of the largest drug-testing laboratories in the country. Despite the increase, the rate remains significantly lower than that in the late 1980s and early 1990s, when rates were in the double digits.

The rate of workforce drug positivity hit a 14-year high in 2018, according to analysis released today by drug-testing firm Quest Diagnostics. Positivity rates in urine drug tests in the combined US workforce rose to 4.4% in 2018, up from 4.2% in 2017. This is the highest level since 4.5% in 2004 and higher than the 30-year low of 3.5% recorded between 2010 and 2012.

The rate of positive drug tests among U.S. workers hit a 14-year high last year with marijuana topping the list of most commonly detected illicit substances, an analysis released today by Quest Diagnostics shows. Ten states and the District of Columbia have OK’d recreational marijuana for adults, and in more than half of all states medical marijuana is legal. The state initiatives pose problems for employers and mariners — or potential mariners — who may use marijuana when not at work. Federal law still considers marijuana illegal, so weed is off limits for those in safety-sensitive jobs under Coast Guard and Department of Transportation (DOT) jurisdiction.

The number of U.S. workers who tested positive for marijuana and other drugs jumped to a 14-year high in 2018, according to the drug-testing laboratory Quest Diagnostics Inc. Quest Diagnostics found that 2.3 percent of 10 million urine, saliva and hair samples from U.S. workers tested positive for marijuana in 2018, a 10-percent increase over the prior year. About 4.4 percent of samples contained some kind of illegal or legal drug, a 14-year high, The Wall Street Journal reports.

Marijuana use is increasing among US workers as more states legalize the drug for recreational and medical consumption, a new study from Quest Diagnostics found. The rate of US workers and job applicants who tested positive for all drugs - including opiates, cocaine, heroin, and marijuana - hit a fourteen year high last year, the study found based on an analysis of nearly 9 million urine tests.

Most employers in New York City would no longer be able to force job applicants to take drug tests for marijuana use, under a bill overwhelmingly approved this week by the City Council. If the drug-screening law is enacted, it would put New York in relatively uncharted territory. Several drug policy and employment experts said that they did not know of similar laws on the books, even in states that have legalized marijuana. Quest Diagnostics, one of the nation’s largest medical testing companies, released data on Thursday that said that marijuana use had risen among United States workers in 2018. An analysis of more than 10 million drug-test results showed that 2.3 percent of the American work force tested positive for marijuana use in 2018, up from 2 percent a year earlier.

More American workers are testing positive for marijuana, a new report finds, as lawmakers in New Jersey and Illinois push to join nearly a dozen more states where recreational use of the drug is now legal. The number of workers and job applicants who tested positive for marijuana climbed 10% last year to 2.3%, according to an analysis of 10 million urine, saliva and hair samples by Quest Diagnostics Inc., one the nation’s largest drug-testing laboratories. The Quest data, which is set to be released Thursday, found 4.4% of the analyzed samples contained traces of both legal and illegal controlled substances including pot, prescription painkillers and other drugs—the highest such rate since 2004.

The rate of U.S. general workforce drug positivity hit a 14-year high in 2018, according to a new drug testing analysis released April 11 by Quest Diagnostics. Positivity rates in the combined U.S. workforce increased nearly 5% in urine drug tests, from 4.2% in 2017 to 4.4% in 2018, climbing to the highest level since 2004 (4.5%). They now are more than 25% higher than the 30-year low of 3.5% recorded each year from 2010-12.

More Americans are showing up for work high or with marijuana in their system, according to a new analysis released Thursday by Quest Diagnostics. Roughly 4.4 percent of more than 10 million workplace drug tests in 2018 showed positive results, marking a 14-year high, Quest said. It represents an increase from 4.2 percent in 2017 and is the highest since 2004, when the provider of diagnostic information services found 4.5 percent of workplace samples tested positive for drugs.

University of Connecticut students who get lab work done at Student Health Services (SHS) can now access the results of that work through their health portal, located at myhealth.uconn.edu. Once students log into their account on the my health portal, they should click on “My Profile,” then click on “Lab History” from the dropdown menu.Lori Masters, director of clinical data analytics and health information management at Student Health and Wellness, said the lab work students get done at SHS is sent to Quest Diagnostics, and after Quest runs tests and gives the results to SHS, the results are available in the health portal within one or two days.

Joey Hale and Ben Ricks were cutting pipe from a scaffold in an elevator shaft last June. Their job was to help turn the hulk of the Old Shoe Co. in St. Louis into a high-end hotel. The cable snapped, and they fell six floors to their death. Neither was wearing a safety harness. They weren't alone. Elevator accidents have more than doubled in recent years, as both older, less-agile workers and younger ones with little or no training are working longer hours in dangerous construction and transportation jobs. There's also a shortage of healthy workers. Many companies have lowered standards to accept people who have failed or barely passed drug tests, according to Quest Diagnostics. Workplace overdoses due to alcohol and drugs have increased by 25 percent for five consecutive years ending 2017, the latest year records are available. The worst states are in the Midwest, according to US Drug Test Centers.

Drug tests are frequently part of an employer’s drug-free workplace program and may require both prospective and current employees, known as donors, to provide a drug test specimen. With urine being the most widely used specimen type, a donor will often visit a collection site and complete a urine drug test collection. The process is typically seamless and straightforward. However, there may be scenarios where witnessing the collection of the specimen is necessary, for example, when a donor takes part in well-choreographed and intentional efforts to undermine, or cheat, the drug test collection process.

Having over the last two decades established themselves in the vaccination space, pharmacies are now moving into point-of-care testing. The spread of POC testing technology along with changes in state regulations and pharmacist education are driving an increase in pharmacist-administered testing, said Michael Klepser, a professor of pharmacy at Ferris State University, whose research focus includes the utility and implementation of pharmacy POC testing.Pharmacy POC testing is distinct from other retail testing models like retail clinics such as CVS' MinuteClinic, which offers a relatively wide range of healthcare services (typically provided by a physician assistant or nurse practitioner), or collaborations between retailers and reference labs like Quest Diagnostics or Laboratory Corporation of America, where the retailers essentially serve as draw centers for these labs.

Nineteen New Jersey companies received perfect scores in the Human Rights Campaign Foundation’s 2019 Corporate Equality Index, used to judge how employers meet the needs of the lesbian, gay, bisexual, transgender, and queer community with policies and practices. Other top-score earners include Subaru of America Inc. in Cherry Hill; Prudential Financial Inc. in Newark; BASF Corp. in Florham Park; ADP in Roseland; Dun & Bradstreet Corp. in Short Hills; Campbell Soup Co. in Camden; Quest Diagnostics Inc. in Lyndhurst; Becton, Dickinson and Co. in Franklin Lakes; Wyndham Destinations in Parsippany; Horizon Healthcare Services Inc. in Newark; Day Pitney LLP in Parsippany; Bayer U.S. LLC in Whippany; Celgene Corp. in Summit; Johnson & Johnson in New Brunswick; Merck in Kenilworth; Sanofi in Bridgewater; Unilever in Englewood Cliffs; and American Express Global Business Travel in Jersey City.

Four companies were recognized for their contributions to Quest while displaying behavior consistent with the company’s values of Quality, Integrity, Innovation, Accountability, Collaboration and Leadership. The awards were given during a meeting which brought together senior executives from over 40 key suppliers.

It has been a tough stretch for health-care stocks in 2019, and there is a good chance it isn’t over yet.[CR-LF][CR-LF]Sen. Bernie Sanders of Vermont is one of several Democratic presidential candidates pushing for Medicare for All. With the 2020 presidential election still 18 months away, the direction of health-care policy is likely to remain.[CR-LF][CR-LF]Quest Diagnostics (DGX) yields 2.2%. The company provides medical tests for a long list of medical conditions, including lung cancer, allergies, and hepatitis C. Last month it was named a preferred labor provider for UnitedHealth.

The reality of legalization in Illinois, if it happens at all, would likely be much hazier. Some employers might start turning a blind eye to employee use - as long as workers can still do their jobs - a trend that's already happening in some other states where it's legal. Other employers, however, might still ban its use, taking action against employees who test positive for pot, bolstered by federal law under which marijuana is still illegal, experts say. In Colorado, about 96 percent of employers who used the drug testing company Quest Diagnostics in 2017 still included marijuana in their employee drug testing, said Dr. Barry Sample, senior director of science and technology for Quest's employers solutions business. In Nevada, where recreational cannabis use is also legal, that number was 91 percent in 2017.

Recent surveys indicate that a majority of the nation's hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day. "Last December, a survey of hospital and health network C-level administrators conducted by Modern Healthcare and Quest Diagnostics revealed that nearly 80% of survey respondents were unaware that their institutions met the definition of 'applicable laboratory' and were thus legally required to report the clinical laboratory test prices they were paid by private health insurers," explained Robert L. Michel, Editor-In-Chief of THE DARK REPORT.

Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, received a perfect score of 100 from the Human Rights Campaign Foundation on the 2019 Corporate Equality Index, earning the distinction of being a "Best Place to Work for LGBTQ Equality." The Corporate Equality Index (CEI) is a national benchmarking survey and report on corporate policies and practices related to LGBTQ workplace equality, administered by the Human Rights Campaign Foundation. This is third year Quest has earned the designation as a Best Place to Work for LGBTQ Equality.

Quest Diagnostics, the world's leading provider of diagnostic information services, hosted Massachusetts Governor Charlie Baker at its state-of-the-art clinical testing laboratory in Marlborough, Massachusetts on Friday, March 29. During the visit Governor Baker toured the laboratory, met with employees, and learned more about the company's initiatives in the areas of pricing transparency, Alzheimer's treatment and detection, and combatting the opioid epidemic. Marlborough Mayor Arthur Vigeant joined Governor Baker on the visit.

The prospect of marijuana legalization might inspire visions of weed-smoking breaks at work, or grabbing a joint with co-workers after a hectic day at the office.[CR-LF][CR-LF]But the reality of legalization in Illinois, if it happens at all, would likely be much hazier. Some employers might start turning a blind eye to employee use — as long as workers can still do their jobs — a trend that’s already happening in some other states where it’s legal. Other employers, however, might still ban its use, taking action against employees who test positive for pot, bolstered by federal law under which marijuana is still illegal, experts say. In Colorado, about 96 percent of employers who used the drug testing company Quest Diagnostics in 2017 still included marijuana in their employee drug testing, said Dr. Barry Sample, senior director of science and technology for Quest’s employers solutions business. In Nevada, where recreational cannabis use is also legal, that number was 91 percent in 2017.

Currently 10 states and Washington, D.C., allow recreational use of marijuana, and Illinois, New Jersey and New York are considering doing the same. This puts companies—already grappling with a shortage of workers—in a bind because an increasing number of candidates are failing routine drug tests due to smoking pot in those states, the Wall Street Journal reports. While legalized marijuana has created jobs and brought in additional tax dollars for those states, the spillover effect has more job applicants unable to pass standard drug tests, according to Quest Diagnostics.

In a perspective article in the New York Times, Dr. Diane M. Simeone, who directs the Pancreatic Cancer Center at New York University Langone Health, suggested that early detection is a solution. Quest Diagnostics found that 5.3 percent of retail workers tested positive for drugs in 2017, up from 4.7 percent in 2015, and the highest of any job sector. The Quest sampling suggests that about 837,000 of the 15.8 million retail workers across the U.S. would have tested positive if all had been checked.

An Arizona company has a new colon cancer blood test on the market that sounds like an enticing alternative to the oft-dreaded colonoscopy. The $170 blood test, called BeScreened-CRC, was developed by Phoenix-based diagnostics laboratory Beacon Biomedical and is a screening tool for colon cancer, its developer says. Sonora Quest Laboratories in Arizona has offered the test since December, and no doctor's order is required. It's not covered by Medicare. Coverage by commercial insurance plans varies.

Quest Diagnostics, the world's leading provider of diagnostic information services, announced today that it will present results of eight studies at the 2019 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting, to be held April 2 – 6, 2019 in Seattle, Wash. (Quest Diagnostics booth 929). These studies by Quest Diagnostics researchers evaluate a broad range of laboratory technologies and best practices for aiding in the evaluation of risk for cancer and other diseases.

Last May, food services and facilities management company Sodexo fired a Massachusetts food supervisor after she tested positive for marijuana. It was standard policy—the employee, Bernadette Coughlin, had fallen at work, breaking her arm, and protocol required a mandatory drug test following an injury. Although Coughlin’s job was not “safety sensitive,” Sodexo’s policy was clear: One strike and you’re out. Quest Diagnostics, the medical testing company, has reported that five out of 16 industries—transportation and warehousing, retail trade, public administration, finance and insurance and wholesale trade—saw double-digit growth in positive drug tests between 2015 and 2017, with marijuana being the most commonly detected substance.

On Mar 22, we issued an updated research report on Quest Diagnostics, Inc. As a part of its two-point strategy, Quest Diagnostics has been focusing on areas with high potential. However, the reimbursement scenario remains a major cause of concern for thisZacks Rank #3 (Hold) company. Quest Diagnostics is currently focusing on diagnostic information services and disciplined capital deployment. Meanwhile, the company’s acquisitions and collaborations with hospitals and integrated delivery networks act as major growth drivers.

Companies facing a shortage of employees from health-care workers to forklift operators are confronting a new challenge: finding candidates who can pass drug tests in states that have legalized marijuana. Mentions Quest Drug Testing Index data.

According to Mayo Medical Laboratories' Jane Hermansen, "the best kept secret" at many of the hospitals she has observed over the course of her career is "the net revenue of their lab outreach programs." Quest in recent years has snapped up the outreach businesses of systems including Pacific Northwest-based PeaceHealth, Connecticut's Backus Hospital and the Hospital of Central Connecticut, and Flint, Michigan's Hurley Medical Center. LabCorp, meanwhile, has purchased businesses including Mount Sinai Clinical Outreach Laboratories, Spokane, Washington-based Pathology Associates Medical Laboratories, and Detroit Medical Center's outreach operation.

You see it in every major town and city. With 6,600 patient access points, Quest Diagnostics Incorporated (DGX) is one of the leading providers of patient diagnostics, laboratory testing, and genetic testing services in the United States. When you consider the importance of diagnostics in the medical field as well as testing services for a US labor force that faces pressure from drugs, Quest Diagnostics seems like a potentially lucrative investment opportunity.

Heightened awareness of the dangers of prescription opioids has prompted a movement to limit use of opioid therapies for patients with acute or chronic pain. Primary care practitioners stand on the front lines of this care shift, and many are curtailing prescribing opioids in response. But is the solution to the drug epidemic this straightforward? These latest data align with findings of an analysis of drug monitoring laboratory tests performed by Quest Diagnostics and published in the Journal of Addiction Medicine.

Quest Diagnostics Chairman, President, and Chief Executive Officer Steve Rusckowski led a group of dignitaries at a groundbreaking ceremony for a new flagship laboratory at the On3 campus earlier this month. With more than 1,100 employees expected to work at the new 250,000-square-foot facility when it opens in 2021, the lab, on the Clifton side of the ON3 campus redevelopment project, will be the company's largest.

The giant inflatable colon stolen from a Kansas City nonprofit last year will soon have a name. Quest Diagnostics and the Colon Cancer Coalition are hosting a naming ceremony Friday, March 1 at noon. Police said last year, thanks to a tip, officers found it in a vacant house near Virginia Avenue and Gregory Boulevard.

Roughly a year after its launch, a pilot project exploring the use of blockchain to manage healthcare provider records is paying off. The effort, which has thus far focused on some 100,000 provider locations across Texas, has produced substantial efficiencies for participating firms, said Jason O'Meara, senior director of architecture at Quest Diagnostics, one of the seven companies comprising the Synaptic Health Alliance, the healthcare industry group leading the project.

Quest Diagnostics said this week that its board has declared a quarterly cash dividend of $.53 per share, payable on April 22 to shareholders of record on April 8. Laboratory Corporation of America recorded net restructuring charges of $48.1 million related to severance and other personnel costs, and integration activities in 2018, it reported in its Form 10K to the US Securities and Exchange Commission this week.

Quest Diagnostics combined its chief information and digital officers into one role and named Gabrielle Wolfson, former Xerox Corp. CIO, to the role in February, according to The Wall Street Journal. Ms. Wolfson comes to Quest with experience managing the technology infrastructure and digital business at Xerox, according to the report. Former Quest Diagnostics CIO Lidia Fonseca left the role last year to take a position as chief digital officer at Pfizer.

Gov. Phil Murphy will reveal a state budget Tuesday that reduces spending on health care for New Jersey’s government workers by $800 million, alleviating at least some pressure on the state to hike major taxes this year, NJ Advance Media has learned. Murphy expects to save $61 million by auditing the insurance rolls and rooting out ineligible dependents, $7.9 million by auditing claims processed by the current pharmacy benefits manager, and $12.5 million by shifting Quest Diagnostics, the popular diagnostic lab, in network, among other changes, including rebidding the state’s contract for a pharmacy benefits manager.

Many of us remember the case of the missing giant inflatable colon. It was a mystery that kept Kansas City residents on the edge of their seats for a dozen days. With the #StolenColon hashtag going viral, many jokes and demands for answers were made all across social media. Now, with Friday marking the start of Colon Cancer Awareness Month, the stolon colon is back to work.

Quest Diagnostics said today it has entered a partnership agreement with Regional Medical Center of Orangeburg, South Carolina.[CR-LF][CR-LF]Under the agreement, Quest will provide RMC with full laboratory management services, including management, equipment, reference testing, supplies, and procurement services.

The cost of healthcare in the U.S. is skyrocketing and employers and lawmakers must play a larger role to reduce the burden on Americans. So far, they aren’t doing enough, experts say. “Vitamin D screenings were in a typical bundle of laboratory services that are already provided,” she said. “[It’s] talking directly to LabCorp and Quest Diagnostics, saying ‘take this off your bundle, it’s no longer needed.’”

Marijuana may be legal now in Michigan, but many employees are likely to face strict workplace policies and still run the risk of being fired. That's partly because the federal government still considers marijuana to be a controlled substance. But whether they do business with Washington, employers face a legal landscape of complicated interactions with their workers. According to the 2017 annual report from Quest Diagnostics, two percent of the drug tests they analyzed nationally tested positive for marijuana.

While cities like New York have cracked down on CBD in food and drinks, that is not case in Kansas City. But how much of it people consume is important and could have an impact on whether or not they land their next job. However, lab-testing company, Quest Diagnostics, wrote in a blog post earlier this month:[CR-LF][CR-LF]"If the CBD product contains THC at a sufficiently high concentration, it is possible, depending on usage patterns, that the use of these products could cause a positive urine drug test result"

Transforming raw data into actionable information is crucial to the financial future of provider organizations, especially as pressure builds on providers to align their care delivery approach with value-based care and consumerism in healthcare. However, many providers lack the time and money to implement this critical function. Fortunately, the right technology can assist providers in getting the most out of their data while freeing up resources better used for patient care. A 2018 Quest Diagnostics survey of physicians and health plan executives found that providers do not have access to the tools they need to succeed under value-based arrangements. Providers still need EHRs, clinical decision support, data analytics, and EHR plug-ins or modules, as well as access to comprehensive patient data.

The American Diabetes Association (the Association) recently released a new economic report that details the fiscal impact of diabetes in the United States – and the results should alarm employers, benefit managers, and HR executives. According to the Association, about 30.3 million people in the U.S. are living with diabetes. In 2017, the total estimated costs associated with diagnosed diabetes were a staggering $327 billion, an increase of 26 percent compared to 2012. About one-third of this cost -- $109 billion -- is due to medical costs to care for patients with diabetes. Another $30 billion is due to indirect costs in the employed population, including increased absenteeism and reduced productivity.

A growing number of employers are adopting workplace wellness programs to improve employee health and subsequently lower their health insurance spend. As they do, benefit managers are tasked with vetting options that will deliver meaningful health and financial results for their companies.A study published in the peer-reviewed journal PLoS ONE, for instance, found that one in three first-time participants in a company-sponsored, lab-based wellness program by Quest Diagnostics were not aware they were at risk for a serious medical condition, such as diabetes or heart disease, according to biometric screening results.

Quest Diagnostics announced today that it will provide full laboratory management services for Georgia-based Houston Medical Center and Perry Hospital. Under the agreement, Quest will provide management expertise, lab equipment, supplies, and procurement processes to the two hospitals. It will also perform reference testing to them. Other terms of the deal were not disclosed.

Quest Diagnostics, the world`s leading provider of diagnostic information services, today announced that its Board of Directors has elected Denise M. Morrison to serve as a director, effective February 18, 2019. Including Ms. Morrison, the company`s Board has 11 members.

Quest Diagnostics Inc. this week named a chief information and digital officer, combining two enterprise technology roles, as digital tools continue to expand beyond providing back-room business support and into strategic data management and analytics. Gabrielle Wolfson, a former Xerox Corp. chief information officer, took on the dual role earlier this month at the medical diagnostic-information provider known for blood work, urinalysis and other laboratory tests, a company spokesperson said.

Quest Diagnostics has signed a definitive agreement to acquire the assets of the clinical laboratory services business of Boyce and Bynum Pathology Laboratories; BBPL’s anatomic pathology division, long-term care division, and Boyce and Bynum Pathology Professional Services are not part of the transaction. Through a separate professional services agreement, BBPPS will become the exclusive pathology provider for Quest clients in Missouri and a preferred pathology provider in the greater Midwestern region. The professional services agreement will go into effect at the time the acquisition is completed, which is expected in the first quarter of 2019.

Quest Diagnostics named Gabrielle Wolfson, a veteran IT business leader, as the company's new senior vice president and chief information and digital officer.

Quest Diagnostics saw fourth-quarter 2018 revenues of $1.84 billion and net income of $127 million. The company should grow by 2% this year, driven by acquisitions, said CEO Steve Rusckowski.

As fentanyl comes and goes in the news, it still remains a serious drug in America. Fentanyl is highly addictive synthetic opioid 50 to 100 times more potent than morphine and 50 times more potent than many forms of heroin. The pharmaceutical drug is manufactured for pain management; however clandestine laboratories also produce the drug and mix in heroin. Sometimes referred to as Apace, China Girl, Dance Fever, or He-Man, the deadly cocktail has infiltrated our streets, neighborhoods, and workplaces.

Quest Diagnostics announced this week that is has completed its previously announced acquisition of the clinical lab services assets of Boyce and Bynum Pathology Laboratories (BBPL). Through a separate professional services agreement, Boyce and Bynum Pathology Professional Services is now the exclusive pathology provider for Quest clients in Missouri, and a preferred pathology provider in the greater Midwest.

Have you heard of cannabidiol (CBD oil)? It's growing in popularity as a natural way to treat epileptic seizures. And more broadly, anxiety and insomnia. The issue is how close CBD is, scientifically, to marijuana.[CR-LF][CR-LF]Marijuana is rich in the compound THC, which gets you high. And while CBD is not pot it does have a tiny bit of THC in it. That has some people wondering if CBD oil can cause someone to fail a drug test. For answers, I'm looking at what federal law says about CBD and I'm reaching out to one of the largest lab-testing companies in America: Quest Diagnostics. Dr. Barry Sample is Quest's director of science and technology. And yes, that's really his name.

Quest Diagnostics today reported a 1 percent year-over-year drop in revenues for the fourth quarter, missing the consensus analyst expectation. Revenue for the three months ended Dec. 31, 2018 was $1.84 billion, down from $1.87 billion in the same quarter last year. The consensus Wall Street estimate was $1.88 billion.

Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December 31, 2018. "In 2018 we grew revenues, adjusted earnings and cash from operations despite some challenges in the marketplace. Quest is well positioned once again in 2019 to deliver on our commitment to grow revenues and earnings, as our in-network status now extends to approximately 90% of commercially insured lives in the U.S.," said Steve Rusckowski, Chairman, CEO and President. "Our guidance for 2019 reflects significant reimbursement pressure offset by strong volume growth and continued execution of our Invigorate program. I am pleased to report our volumes for the year are off to a good start."

Ms. Wolfson is responsible for leading information technology, data informatics and digital solutions for Quest Diagnostics. These include the company’s Quanum™ suite of healthcare IT solutions and data analytics, myQuest patient mobile app and portal, and digital engagement for the company’s 2,200 patient service centers.

Quest Diagnostics: Q4 Non-GAAP EPS of $1.36 misses by $0.01; GAAP EPS of $0.92 misses by $0.27.

Quest Diagnostics, the world's leading provider of diagnostic information services, and Houston Healthcare are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through a new partnership agreement under which Quest will provide full laboratory management services for Houston Medical Center and Perry Hospital.

Secaucus-based Quest Diagnostics announced Monday it has completed its previously announced acquisition of the clinical laboratory services business of Boyce & Bynum Pathology Laboratories. BBPL, based in Columbia, Missouri, is a provider of diagnostic and clinical laboratory services in the Midwest. Through a separate agreement, BBPL has been named the exclusive pathology provider for Quest Diagnostic clients in Missouri.

IBM Watson Health today announced an expansion to its partnership with the Broad Institute, providing artificial intelligence to help clinicians mine genomic data to predict patient risk for cardiovascular disease. IBM Watson and the Broad already are a little more than two years into a five-year, $50 million research initiative that seeks to discover the basis for drug resistance in cancers. The Broad is a partner in IBM Watson Genomics from Quest Diagnostics, a service that is available to oncologists nationwide that focuses on oncology diagnostics and providing options for evidence-based methods of treating cancer.

The stigma around marijuana use, both medical and recreational, is slowly dwindling as states throughout the country work towards marijuana legalization. 33 states have officially declared medical marijuana use legal and 10 states have legalized recreational use of the drug. However, a question lingers nationwide regarding views of marijuana in the workplace. All companies hold the right to drug test their employees; however, some industries feel that it’s necessary to test for marijuana regularly while others don’t. On the flip side, there is a large number of companies that don’t drug test as heavily — and that number is growing. With drug tests costing companies around $30 to $50 per employee, many see it as a wasted expense. Quest Diagnostics said that failed drug tests reached an all-time high in 2017 and this is likely to increase as legalization becomes more widespread. Drug testing restricts the job pool, meaning companies aren’t able to find the best candidates for open positions.

The most recent short interest data has been released for the 01/31/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded.

Quest Diagnostics, the world's leading provider of diagnostic information services, announced that it has completed its previously announced acquisition of the clinical laboratory services business of Boyce & Bynum Pathology Laboratories (BBPL), a leading provider of diagnostic and clinical laboratory services in the Midwest.

A diagnostic test used by Mayo Clinic to detect a rare neurological disease involves standard techniques and is not subject to patent law, a federal appeals court ruled Wednesday. The appellate court's decision to uphold a district court ruling in the patent dispute effectively denied claims by Quest Diagnostics' Athena Diagnostics division that it was owed royalties for the testing. The US Court of Appeals for the Federal Circuit sided with Mayo in a 2-1 decision.

Back in 2017, Microsoft first announced the new AI-powered research project under Healthcare NExT initiative that enables healthcare providers to easily create intelligent and compliant healthcare virtual assistants and chatbots. Last year, Microsoft announced the preview of Healthcare Bot service on Azure Marketplace that enabled healthcare organizations to build and deploy, AI-powered virtual health assistants and chatbots. Microsoft today announced the general availability of the service. Virtual health assistants built using this service can be used for enhancing processes, self-service support, and cost reduction efforts. Quest Diagnostics in Cary, NC recently built a bot using the Microsoft Healthcare Bot service. This bot helps Quest Diagnostics' patients in finding testing locations, schedule appointments and get answers to non-medical questions such as whether to fast before a blood test or when to expect results.

Several large health insurance companies, including Aetna, Anthem, and Healthcare Service Corporation, have announced a collaboration with PNC Bank and IBM to utilize blockchain technology to “improve transparency and interoperability in the health care industry” and “address a range of industry challenges, including promoting efficient claims and payment processing, to enable secure and frictionless healthcare information exchanges, and to maintain current and accurate provider directories.” The Synaptic Health Alliance launched in April 2018 with Humana, MultiPlan, Quest Diagnostics, UnitedHealthcare and Optum.

Prism Capital Partners announced it is planning new developments at ON3, a 116-acre campus spanning the cities of Clifton and Nutley Township. The planned construction projects will add approximately 400,000 square feet of laboratory facilities. Prism also stated it is finalizing plans to build a four-story, 150,000-square-foot speculative laboratory building at ON3. Additionally, Quest Diagnostics, leading provider of diagnostic information services, will break ground imminently for a flagship laboratory on a 12-acre parcel. The 250,000-square-foot, owner-occupied lab will become the largest in Quest’s network of 20-plus major laboratory facilities across the country, and will employ more than 1,100 people.

As the industry moves beyond mere EHR adoption and meaningful use, small practices of 10 physicians or fewer told researchers that they want their EMRs to do more than just meet regulatory requirements, a new KLAS report on small physician practices finds. But first, they want the basics to just work better. That means tailoring usability for them and improving customer service. As part of this research, KLAS interviewed representatives from AdvancedMD, Allscripts, Aprima, athenahealth, Azalea Health, CareCloud, Cerner, CureMD, eMDs, Greenway Health, Kareo, NextGen Healthcare, Quest Diagnostics, and Virence Health (GE Healthcare) to determine how well the vendors were aligned with the small practices’ needs and what is driving dissatisfaction among small groups.

Drug testing can be complicated. Much like a baseball player, you must learn the fundamentals of drug testing to execute a successful, drug-free workplace program. No one hits a home run the first time up to bat. Whether you are a drug testing rookie or a veteran, it’s important to understand the benefits of different specimen types and what test type fits the unique needs of your workforce. In our upcoming webinar series, Back to Basics, we take a closer look at the three most common test types for drug testing offered by Quest Diagnostics: urine, hair, and oral fluid.

Americans have multiple numbers at their fingertips, but some of the numbers that could be most important to their health are not among them. New research released today by Quest Diagnostics, the world’s leading provider of diagnostic insights, shows that a majority of adults don’t know vital health information for them or their family members, but nearly all would like to be able to access their health information online. Results from the “Know Your Numbers“ survey show that more people remember their social media log-ins, current bank balances, Wi-Fi-passwords and even the security code on the back of their credit card than they do important personal health data, including their blood type and cholesterol and blood sugar levels.

Mike Sims owns Charlotte CBD on Central Avenue in Charlotte. Their business is exploding and they’ve only been open 18 weeks. “We thought it would be successful but nothing like we’ve seen,” says Owens while a wave of customers shopped in his store. So what if you use a CBD product and have to take a random drug test? We posed that question to Dr. Barry Sample with Quest Diagnostics, the nation’s leading provider in drug testing, where millions of drug tests are administered every year.

A 2017 survey conducted by the National Safety Council found employee use of prescription drugs on the job had affected a majority of employers. The most significant effect was absenteeism or missed work (reported by 39 percent of respondents) followed by impaired or decreased job performance (reported by 29 percent) and safety concerns, such as injuries or near misses (reported by 15 percent). However, a more recent report from December 2018 is cause for even more concern—the use of non-prescription drugs in the workplace.

A 2017 survey conducted by the National Safety Council found employee use of prescription drugs on the job had affected a majority of employers. The most significant effect was absenteeism or missed work (reported by 39 percent of respondents) followed by impaired or decreased job performance (reported by 29 percent) and safety concerns, such as injuries or near misses (reported by 15 percent). However, a more recent report from December 2018 is cause for even more concern—the use of non-prescription drugs in the workplace. A new report published by Quest Diagnostics notes such drug use among the U.S. workforce is increasing at an alarming rate.

Data detailed on Oncology - Chronic Lymphocytic Leukemia have been presented. According to news reporting originating from Marlborough, Massachusetts, by NewsRx correspondents, research stated, "The prognostic role of cytogenetic analysis is well-established in B-cell chronic lymphocytic leukemia (CLL). Approximately 80% of patients have a cytogenetic aberration." Our news editors obtained a quote from the research from Quest Diagnostics, "Interphase FISH panels have been the gold standard for cytogenetic evaluation, but conventional cytogenetics allows detection of additional abnormalities, including translocations, complex karyotypes and multiple clones.

In 2018, five major healthcare companies - Humana, MultiPlan, Optum, Quest Diagnostics, and UnitedHealthcare - formed the Synaptic Health Alliance (the `Alliance`) to explore how blockchain technology could resolve current healthcare issues.

Delta County residents will want to mark their 2019 calendars for Delta County community-wide health fairs which include early blood draw events in early February or health fairs in mid-March in Paonia, Cedaredge and Delta. Delta County Memorial Hospital Volunteers and Lions clubs in Delta, Cedaredge and Paonia will be partnering in the annual community health fair events again. There will be no price increases on the cost of any of the blood work in 2019. Quest Diagnostics will be providing the health screen results in a booklet format to help health fair participants easily understand the meaning of each of the health screen results.

Marijuana is the substance most often detected in workplace drug screenings, according to a new study. More and more employees are testing positive for drugs in workplace screenings, an increase that is concerning for some employers and safety specialists. According to a study by Quest Diagnostics, positive drugs tests have increased significantly in a two-year period between 2015 and 2017.

The idea of sunshine in a bottle vitamin D supplementation — has been promoted as a possible fix for everything from bone and immune system health to depression, dementia and diabetes, and the premise sells. According to recent CDC statistics, approximately 45% of middle-aged women and 38% of middle-aged men report taking a vitamin D supplement, and hundreds of thousands of Americans get tested for vitamin D deficiency each year. VITAL was supported by the NIH. Manson reports she received grants from the NIH, nonfinancial support from BASF, Pharmavite, Pronova BioPharma and Quest Diagnostics during the conduct of the VITAL study. Ng has received research funding from Pharmavite. Bernal-Mizrachi, Clarke and Michos report no relevant financial disclosures.

IBM is collaborating with a group of major players in the healthcare space to improve the way sensitive data is shared and make health claims and transactions more efficient – all in the form of a “blockchain-based ecosystem.” In such a busy space it’s not surprising IBM is faced with some consortia competition. For example, in April of last year, Humana and United Health Group, two of the largest health insurers, teamed up on a blockchain pilot with data providers Quest Diagnostics, Multiplan and Optum.

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2019 for the fourth consecutive year. The annual survey designated Quest Diagnostics as one of only five companies to attain Most Admired status in the "Health Care: Pharmacy and Other Services" industry category.

Good Leads has experience in generating technology sales leads with providers such as Quest Diagnostics, Samsung Neurologica , Fuji Medical, Statlife and Quality Interactions and regularly attends HIMSS and RSNA conferences in support of their IT healthcare and radiology focused customers.

Quest Diagnostics and Oxford Immunotec announced that Quest has completed its acquisition of the U.S. laboratory services business of Oxford Immunotec; the T-Spot.TB tuberculosis and the Accutix tick-borne disease testing services are now part of Quest’s portfolio of infectious disease testing services.

Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 37th Annual J. P. Morgan Healthcare Conference in San Francisco. Stephen Rusckowski, Chairman, President and CEO and Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, January 8, 2019 at 7:30 p.m. Eastern Time. Mr. Rusckowski and Mr. Guinan also will participate in a Q&A session moderated by the host analyst.

The Centers for Disease Control and Prevention (CDC) reported that more than 70,000 people in the United States died of drug overdoses in 2017. That devastating number broke records as the highest number for any single year in our country’s history and contributed to a decrease in life expectancy. Today drug overdoses rank as the leading cause of death for adults under age 55. DownloadQuest Diagnostics white paper about how the opioid crisis affects the workplace.

UBS initiated coverage of Quest Diagnostics and Laboratory Corporation of America on Thursday with a Neutral and Buy rating, respectively. In a report, analyst Kevin Caliendo put a a 12-month price target in Quest's shares of $90 and wrote that while he believes Quest could take market share from LabCorp and other competing reference labs, his analysis of Quest's long-term strategic partnership with UnitedHealthcare, announced in May, "suggests less switching to Quest than is expected."

A recent press release by Quest Diagnostics released new research showing that majority of adults don't know their vital health information, but would like to be able to access their health information online.

The rate of positive drug tests rose by double digits in five of 16 major U.S. workforce industry sectors from 2015 to 2017, according to a recent analysis by lab services provider Quest Diagnostics.

Patient health literacy and knowledge about their own medical information leaves a lot to be desired, leading to calls for better patient education about patient portal and data access, according to a survey conducted by Kelton Global on behalf of Quest Diagnostics.

The rate of positive drug tests rose by double digits in five of 16 major U.S. workforce industry sectors from 2015 to 2017, according to a recent analysis by lab services provider Quest Diagnostics. An examination of data from more than 10 million urine drug tests conducted over the three-year period showed that transportation and warehousing had the largest increase, at 21.4 percent, followed by other services except public administration (15.4 percent), finance and insurance (13), retail trade (12.8), and wholesale trade (11.8).

With trends in drug misuse shifting, Quest Diagnostics is using data mining to help clinicians stay on top of the problem. Quest annually mines and analyzes data from millions of drug tests performed at its laboratories across the country. Last fall, the company released its annual Health Trends, Drug Misuse in America 2018 report, based on 3.9 million de-identified, aggregated lab tests conducted at the Quest laboratories between 2011 and 2017. The mining exercise, and the resulting annual report, are intended to serve as a guide for the clinicians it serves, and for its own laboratories looking to better prepare to meet drug testing needs.

Beginning Jan. 1, 2019, employees and their families who have enrolled with Penn State health benefits will pay the least amount of coinsurance (10 percent), after their deductible, for lab services by using Quest Diagnostics or LabCorp.

Doctors and patients alike need to look at the numbers associated with their hormone levels. The different lab companies that run the blood tests intended to check your hormone levels, such as LabCorp or Quest Diagnostics, have differing ranges for normal, and those may be lowered every few years.

Quest Diagnostics CEO Steve Rusckowski on where the opportunities for growth are for the laboratory-services company, the growth of the health-care sector and efforts to reduce health-care spending in America.

Before you take a vitamin D supplement, you need to get your vitamin D levels checked. This can be done by your doctor, or you can even have it done very inexpensively through a lab such as LabCorp or Quest Labs.

Tom Romeo, general manager of healthcare IT and Quanum Solutions at Quest Diagnostics, recommended hiring the right staff and utilizing their strengths appropriately.

With more and more states legalizing marijuana, you'll often see headlines about how many workers in America are using cannabis. But when you dig into the numbers, it really isn't worth talking about. It should also be noted that all these statistics come from one drug testing lab called Quest Diagnostics. And while Quest Diagnostics is the largest testing lab in the United States, it's not the only one.